NDC 46066-805-50 - Cal Dex CMPK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 46066-805
- Requested NDC
- 46066-805-50
- Package NDCs from labels
- 46066-805-50
- Manufacturer
- Aspen Veterinary
- Effective date
- 2026-03-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cal Dex CMPK - Aspen Veterinary | Aspen Veterinary | 2026-03-20 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46066-805-50 | Cal Dex CMPK | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 727be945-df2a-4fbf-ade4-f242e2647976 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 302b3fa7-ea87-4bf1-aae0-6a2d7459de86 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | dddd2701-4d46-44de-a9f8-303d4dcceef7 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules India Ltd | 60285a8d-bcb0-40ba-b359-df5c89480cd6 | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules India Ltd | 113c031c-6de3-4497-a57d-9740b1ce08ac | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | IPG Pharmaceuticals, Inc. | 5dad0879-0f97-4c7d-98fa-baaed51cd2d8 | 2026-10-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | QUAGEN PHARMACEUTICALS LLC | 8fac192f-48ab-4def-9c3a-f1cd50b3e2b7 | 2026-09-29 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | American Health Packaging | 7c8dd5b0-db93-430f-8bf8-0318504f744c | 2026-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Saptalis Pharmaceuticals, LLC | 483f338e-a164-4c1f-a34e-fef3312cb7ec | 2026-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 27YLU75U4W |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | c2028705-9e5b-424b-983a-1c7a71dedd74 | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9b26cc41-3725-4ef1-afdf-5992816d3b0d | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | REMEDYREPACK INC. | d1e55181-6f85-42c9-922c-808494b6399a | 2026-09-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | e2638b45-1141-4391-971d-c0dea825e41c | 2026-09-11 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2026-09-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| calcium gluconate | CALCIUM GLUCONATE | REMEDYREPACK INC. | d6db3a1c-ed02-48fc-9134-ea1d58acf42e | 2026-09-08 | Warnings, Adverse reactions | CZN0MI5R31 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.